PBL - Innovation in Life Sciences
Early Stage Technology Investment, IP Management and Licensing
PBL develops innovative technologies from public and private sources worldwide - turning ideas into patented, scientifically validated and licensable technologies. PBL invests in building intellectual property protection, and develops technologies through proof-of-concept and prototype stage and licenses onwards to a wide variety of industry sectors. Our interests cover AgBiotech, Food / Nutrition, Microbiology, Biotechnology and related Life Science industries. We market our technologies internationally and have regular contact with a very wide range of industrial customers, licensees and development partners.
PBL was formed in 1994, and is now jointly and equally owned by The John Innes Centre, The Sainsbury Laboratory, and the BBSRC (Biotechnology and Biological Sciences Research Council).
Technology Investment Services for Public Sector Researchers
We offer various options for our services but most commonly work on a fully contingent, non-fee basis, instead taking a portion of future commercial revenues, shared with the original source of the technology. We commonly cover patent costs and can inject funds directly to carry out critical proof-of-concept or technology development work.
Please click here for more information.
IP Management and Patent Advisory Service for Bioscience Companies and Investors
PBL offers bioscience companies and investors a patent consultation and management service including: IP identification and assessment; IP strategy definition; IP portfolio management; IP due diligence.
Please click here for more information.
|
|
Latest News
Key regulator of plant root growth identified
February 2010
More Info...
Sarum Biosciences signs licence agreement with PBL for Clostridium difficile bacteriophage endolysin technology
January 2010
More Info...
PBL / John Innes Centre technology instrumental in Medicago’s flu vaccine production
August 2009
More Info...
PBL among "Innovative exporters vital to UK economy"
July 2009
More Info...
£13.1m Investment for Novacta
July 2009
More Info...
Natural Product Crop Protection Technology Licensed
June 2009
More Info...
|
